Advertisement
Advertisement
U.S. markets close in 9 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Alphamab Oncology (9966.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
13.240+0.440 (+3.44%)
At close: 04:08PM HKT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/13/2021
Current
Market Cap (intraday)
15.54B
Enterprise Value
13.56B
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
6.29
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
-24.87

Trading Information

Stock Price History

Beta (5Y Monthly) -0.16
52-Week Change 3-18.26%
S&P500 52-Week Change 318.83%
52 Week High 328.700
52 Week Low 39.900
50-Day Moving Average 315.380
200-Day Moving Average 318.309

Share Statistics

Avg Vol (3 month) 33.31M
Avg Vol (10 day) 32.51M
Shares Outstanding 5936.99M
Implied Shares Outstanding 6N/A
Float 8347.39M
% Held by Insiders 153.85%
% Held by Institutions 120.66%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Jun 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,090.42%

Management Effectiveness

Return on Assets (ttm)-10.56%
Return on Equity (ttm)-25.77%

Income Statement

Revenue (ttm)42.44M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-26.80%
Gross Profit (ttm)44.9M
EBITDA -438.76M
Net Income Avi to Common (ttm)-592.03M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.92B
Total Cash Per Share (mrq)2.05
Total Debt (mrq)313.19M
Total Debt/Equity (mrq)15.58
Current Ratio (mrq)5.29
Book Value Per Share (mrq)2.15

Cash Flow Statement

Operating Cash Flow (ttm)-415.36M
Levered Free Cash Flow (ttm)-337.95M
Advertisement
Advertisement